TG Therapeutics (TGTX)
(Delayed Data from NSDQ)
$23.83 USD
+0.50 (2.14%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $23.82 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $0.03 | 0.00% |
Earnings Summary
For their last quarter, TG Therapeutics (TGTX) reported earnings of $0.04 per share, beating the Zacks Consensus Estimate of $-0.04 per share. This reflects a positive earnings surprise of 200.00%. Look out for TGTX's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year decrease of 95.89%.
Earnings History
Price & Consensus
Zacks News for TGTX
TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates
TGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services